NCT01897519

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: AbbVie · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

Conditions

• Cardiothoracic Surgery
• Vascular Surgery

Interventions

Type	Name	Description
DRUG	Placebo	Placebo infusion
DRUG	ABT-719	Arm 1 lower dose, arm 2 intermediate dose, arm 3 high dose

Timeline

• Start date: 2013-05-01
• Primary completion: 2014-05-01
• Completion: 2014-05-01
• First posted: 2013-07-12
• Last updated: 2014-06-06

Locations

23 sites across 2 countries: United States, Denmark